Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.
Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D
Diet-Induced Hyperhomocysteinemia Increases Amyloid-beta Formation and Deposition in a Mouse Model of Alzheimer's Disease
Current Alzheimer Research (2010) 7:140-149.
Abstract
Hyperhomocysteinemia (HHcy) has been recognized as a risk factor for developing Alzheimer's disease (AD). However, its underlying molecular mechanisms are still elusive. Here we show that HHcy induces an elevation of amyloid beta (A beta) levels and deposition, as well as behavioral impairments, in a mouse model of AD-like amyloidosis, the Tg2576 mice. This elevation is not associated with significant change of the steady state levels of the A beta precursor protein (APP), beta- or alpha-secretase pathways, nor with the A beta catabolic pathways. By contrast, HHcy significantly reduces glycogen synthase kinase 3 (GSK3) Ser21/9 phosphorylation, but not total GSK3 protein levels. Similar results are obtained in brains homogenates from a genetic mouse model of HHcy. In vitro studies show that homocysteine increases A beta formation, reduces phosphorylated GSK3 levels, without changes in total APP and its metabolism, and these effects are prevented by selective GSK3 inhibition. Overall, these data support a potential link between GSK3 and the pro-amyloidotic effect of HHcy in vivo and in vitro.
Note
Publication Date: 2010-03-01.
PMCID: NIH funded - needs PMCID
Back
Last updated on Wednesday, February 05, 2020